The Medical Research Council (MRC) Molecular Haematology Unit at the University of Oxford (MRC MHU) investigates the processes by which multipotential haemopoietic stem cells become committed and differentiate into the highly specialised cells found in the peripheral blood (red cells, granulocytes, lymphocytes and platelets). The MRC MHU studies how these processes are perturbed in acquired and inherited blood diseases (for example thalassaemia, myelodysplasia and leukaemias). MRC MHU research is closely integrated with the NHS, giving access to patients with haematological disease and clinical material, thus ensuring that the Unit’s scientific developments can be rapidly translated into improved clinical care. The unit collaborates closely with other groups in the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
Find out more about the MRC Molecular Haematology Unit.
Last updated: 31 March 2022